$0.76
-0.01[-1.30%]
Last update: 3:59PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$0.721
-0.0390[-5.13%]
| Open0.721 | Close0.760 |
| Vol / Avg.5.668K / 26.048K | Mkt Cap8.903M |
| Day Range0.721 - 0.800 | 52 Wk Range0.610 - 1.250 |
Virpax Pharmaceuticals Stock (NASDAQ:VRPX), Key Statistics
Virpax Pharmaceuticals Stock (NASDAQ: VRPX) analysis, key statistics.
Valuation Measures
Enterprise Value
-5.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.73
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-170.13%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.05
Tangible Book value per share
1.05
Total Liabilities (Quarterly)
3.6M
Total Assets
16M
Total Liabilities
3.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Virpax Pharmaceuticals Stock (NASDAQ:VRPX), Key Statistics
Virpax Pharmaceuticals Stock (NASDAQ: VRPX) analysis, key statistics.
Valuation Measures
Enterprise Value
-5.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.73
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-170.13%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.05
Tangible Book value per share
1.05
Total Liabilities (Quarterly)
3.6M
Total Assets
16M
Total Liabilities
3.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Virpax Pharmaceuticals Stock (NASDAQ:VRPX), Key Statistics
Virpax Pharmaceuticals Stock (NASDAQ: VRPX) analysis, key statistics.
Valuation Measures
Enterprise Value
-5.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.73
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-170.13%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.05
Tangible Book value per share
1.05
Total Liabilities (Quarterly)
3.6M
Total Assets
16M
Total Liabilities
3.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Virpax Pharmaceuticals Stock (NASDAQ:VRPX), Key Statistics
Virpax Pharmaceuticals Stock (NASDAQ: VRPX) analysis, key statistics.
Valuation Measures
Enterprise Value
-5.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.73
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-170.13%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.05
Tangible Book value per share
1.05
Total Liabilities (Quarterly)
3.6M
Total Assets
16M
Total Liabilities
3.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Virpax Pharmaceuticals Stock (NASDAQ:VRPX), Key Statistics
Virpax Pharmaceuticals Stock (NASDAQ: VRPX) analysis, key statistics.
Valuation Measures
Enterprise Value
-5.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.73
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-170.13%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.05
Tangible Book value per share
1.05
Total Liabilities (Quarterly)
3.6M
Total Assets
16M
Total Liabilities
3.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Virpax Pharmaceuticals Stock (NASDAQ:VRPX), Key Statistics
Virpax Pharmaceuticals Stock (NASDAQ: VRPX) analysis, key statistics.
Valuation Measures
Enterprise Value
-5.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.73
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-170.13%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.05
Tangible Book value per share
1.05
Total Liabilities (Quarterly)
3.6M
Total Assets
16M
Total Liabilities
3.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Virpax Pharmaceuticals Stock (NASDAQ:VRPX), Key Statistics
Virpax Pharmaceuticals Stock (NASDAQ: VRPX) analysis, key statistics.
Valuation Measures
Enterprise Value
-5.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.73
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-170.13%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.05
Tangible Book value per share
1.05
Total Liabilities (Quarterly)
3.6M
Total Assets
16M
Total Liabilities
3.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Virpax Pharmaceuticals Stock (NASDAQ:VRPX), Key Statistics
Virpax Pharmaceuticals Stock (NASDAQ: VRPX) analysis, key statistics.
Valuation Measures
Enterprise Value
-5.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.73
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-170.13%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.05
Tangible Book value per share
1.05
Total Liabilities (Quarterly)
3.6M
Total Assets
16M
Total Liabilities
3.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Virpax Pharmaceuticals Stock (NASDAQ:VRPX), Key Statistics
Virpax Pharmaceuticals Stock (NASDAQ: VRPX) analysis, key statistics.
Valuation Measures
Enterprise Value
-5.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.73
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-170.13%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.05
Tangible Book value per share
1.05
Total Liabilities (Quarterly)
3.6M
Total Assets
16M
Total Liabilities
3.6M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -